FH is due to mutations in three canonical genes, which encodeLDLR, apolipoprotein B (apoB), or PCSK9, accountingfor approximately 90%, 5%, and 1% of all patients, respectively. This evidence concerns the gene APOB and familial hyperaldosteronism.